Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test

Abstract

Aims To assess the cognitive impairment of multiple sclerosis (MS) patients using the Brief Repeatable Battery-Neuropsychology (BRB-N) test.

Methods The performance of 59 patients with MS in the BRB-N test was assessed and compared with 152 matched healthy controls (HC).

Results In most tests, MS patients performed worse than controls. Age and educational level strongly influenced the performance of the subjects. The Symbol Digit Modality Test (SDMT) best correlated with the other individual tests and contributed most to the general BRB-N factor. Furthermore, a correlation between physical disability and performance in some BRB-N tests was observed. Indeed, patients with progressive MS and greater physical disability performed worse in some tests than less disabled patients with relapsing MS. By creating a global BRB-N Z score, we found that patients generally performed 0.7 standard deviation (SD) below the level of controls. We obtained cut-off values stratified by age and education to determinate cognitive impairment in MS patients.

Conclusions Our data show that cognitive impairment is prevalent amongst MS patients, and that a single cognitive measurement might be useful for monitoring patients during the progression of this illness.

Keywords

Brief Repeatable Battery cognitive impairment multiple sclerosis neuropsychology stratified cut-offs

Get full access to this article

View all access options for this article.

References

Compston A , Coles A. Multiple sclerosis . Lancet 2002; 359: 1221-1231 .

Rao SM , Leo GJ , Bernardin L , Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction . Neurology 1991; 41: 685-691 .

Rao SM , Leo GJ , Ellington L , Nauertz T , Bernardin L , Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning . Neurology 1991; 41: 692-696 .

Rao SM. Neuropsychology of multiple sclerosis . Curr Opin Neurol 1995; 8: 216-220 .

Demaree HA , DeLuca J , Gaudino EA , Diamond BJ. Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation . J Neurol Neurosurg Psychiatry 1999; 67: 661-663 .

Achiron A , Ziv I , Djaldetti R , Goldberg H , Kuritzky A , Melamed E. Aphasia in multiple sclerosis: clinical and radiologic correlations . Neurology 1992; 42: 2195-2197 .

Late S , Hemline P , Revonsuo A , Portin R , Ruutiainen J. Sematic memory deficit in multiple sclerosis; impaired understanding of conceptual meanings . J Neurol Sci 1999; 162: 152-161 .

Dujardin K , Donze AC , Hautecoeur P. Attention impairment in recently diagnosed multiple sclerosis . Eur J Neurol 1998; 5: 61-66 .

Ruggieri RM , Palermo R , Vitello G , Gennuso M , Settipani N , Piccoli F. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS B > or = 3.5 . Acta Neurol Scand 2003; 108: 323-326 .

10.

Beatty WW , Goodkin DE. Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination . Arch Neurol 1990; 47: 297-301 .

11.

Rao SM , in collaboration with the Cognitive Function Study Group of the National Multiple Sclerosis Society . A manual for the Brief Repeatable Battery of Neuropsychological Tests in multiple sclerosis. Section of Neuropsychology, Medical College of Wisconsin, 1000 N. 92 Street, Milwaukee, WI 53226 , 1990.

12.

Huijbregts SCKN , de Sonneville LM , de Groot V , Reuling IE , Polman CH. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS . Neurology 2004; 63: 335-339 .

13.

European Study Group on interferon beta-1b in secondary progressive MS. Placebo-controlled multi-centre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis . Lancet 1998; 352: 1491-1497 .

14.

Poser CM , Paty DW , Scheinberg L , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227-231 .

15.

Folstein MF , Folstein SE , McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res 1975; 12: 189-198 .

16.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-1452 .

17.

Fischer JS , Rudick RA , Cutter GR , Reingold SC , Baier ML , Cookfair DL et al. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force . Mult Scler 1999; 5: 244-250 .

18.

Cutter GR , Baier ML , Rudick RA , Cookfair DL , Fischer JS , Petkau J et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure . Brain 1999; 122 (Pt 5): 871-882 .

19.

Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients . Neurology 1997; 48: S10-S16 .

20.

Hamilton M. A rating scale for depression . J Neurol Neurosurg Psychiatry 1960; 23: 56-62 .

21.

Boringa JB , Lazeron RH , Reuling IE , Ader HJ , Pfennings L , Lindeboom J et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice . Mult Scler 2001; 7: 263-267 .

22.

Solari A , Mancuso L , Motta A , Mendozzi L , Serrati C. Comparison of two brief neuropsychological batteries in people with multiple sclerosis . Mult Scler 2002; 8: 169-176 .

23.

Aupperle RL , Beatty WW , Shelton Fde N , Gontkovsky ST. Three screening batteries to detect cognitive impairment in multiple sclerosis . Mult Scler 2002; 8: 382-389 .

24.

Benedict RH , Fischer JS , Archibald CJ , Arnett PA , Beatty WW , Bobholz J et al. Minimal neuropsychological assessment of MS patients: a consensus approach . Clin Neuropsychol 2002; 16: 381-397 .

25.

De Sonneville LM , Boringa JB , Reuling IE , Lazeron RH , Ader HJ , Polman CH. Information processing characteristics in subtypes of multiple sclerosis . Neuropsychologia 2002; 40: 1751-1765 .

26.

Christodoulou C , Krupp LB , Liang Z , Huang W , Melville P , Roque C et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients . Neurology 2003; 60: 1793-1798 .

27.

Beatty WW , Goodkin DE , Hertsgaard D , Monson N.

Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter?

Arch Neurol 1990; 47: 305-308 .

28.

Foong J , Rozewicz L , Chong WK , Thompson AJ , Miller DH , Ron MA. A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis . J Neurol 2000; 247: 97-101 .

29.

Vleugels L , Lafosse C , van Nunen A , Nachtergaele S , Ketelaer P , Charlier M et al. Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks . Mult Scler 2000; 6: 241-254 .

30.

Kujala P , Portin R , Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3- year follow-up . Brain 1997; 120 (Pt 2): 289-297 .

31.

Smith A. The Symbol Digit Modalities Test manual. Los Angeles: Western Psychological Services , 1982.

32.

Filley CM , Heaton RK , Nelson LM , Burks JS , Franklin GM. A comparison of dementia in Alzheimer’s disease and multiple sclerosis . Arch Neurol 1989; 46: 157-161 .

33.

Comi G , Filippi M , Martinelli V , Campi A , Rodegher M , Alberoni M et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis . J Neurol Sci 1995; 132: 222-227 .